[go: up one dir, main page]

FR3068366B1 - Procede de production de progeniteurs erythroides - Google Patents

Procede de production de progeniteurs erythroides Download PDF

Info

Publication number
FR3068366B1
FR3068366B1 FR1756222A FR1756222A FR3068366B1 FR 3068366 B1 FR3068366 B1 FR 3068366B1 FR 1756222 A FR1756222 A FR 1756222A FR 1756222 A FR1756222 A FR 1756222A FR 3068366 B1 FR3068366 B1 FR 3068366B1
Authority
FR
France
Prior art keywords
erythroid progenitors
producing erythroid
producing
bringing
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1756222A
Other languages
English (en)
Other versions
FR3068366A1 (fr
Inventor
Laurence Guyonneau-Harmand
Loic Garcon
Frédéric Aurade
Nicolas Rebergue
Frédéric Relaix
Luc Douay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Francais du Sang Ets
Sorbonne Universite
Original Assignee
Universite Pierre et Marie Curie
Institut National de la Sante et de la Recherche Medicale INSERM
Francais du Sang Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1756222A priority Critical patent/FR3068366B1/fr
Application filed by Universite Pierre et Marie Curie, Institut National de la Sante et de la Recherche Medicale INSERM, Francais du Sang Ets filed Critical Universite Pierre et Marie Curie
Priority to AU2018293389A priority patent/AU2018293389B2/en
Priority to US16/627,396 priority patent/US20200370015A1/en
Priority to EP18733656.5A priority patent/EP3645707A1/fr
Priority to PCT/EP2018/067833 priority patent/WO2019002625A1/fr
Priority to JP2019572440A priority patent/JP7162625B2/ja
Priority to CA3067551A priority patent/CA3067551A1/fr
Priority to KR1020207002966A priority patent/KR102744512B1/ko
Priority to CN201880044213.0A priority patent/CN111373029B/zh
Publication of FR3068366A1 publication Critical patent/FR3068366A1/fr
Application granted granted Critical
Publication of FR3068366B1 publication Critical patent/FR3068366B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/45—Artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé de production in vitro de progéniteurs érythroïdes comprenant la mise en contact de cellules souches hématopoïétiques, génétiquement modifiées ou non, avec un milieu de culture cellulaire défini comprenant une hormone glucocorticoïde et un inducteur d'autophagie.
FR1756222A 2017-06-30 2017-06-30 Procede de production de progeniteurs erythroides Active FR3068366B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR1756222A FR3068366B1 (fr) 2017-06-30 2017-06-30 Procede de production de progeniteurs erythroides
US16/627,396 US20200370015A1 (en) 2017-06-30 2018-07-02 Method for producing erythroid progenitor cells
EP18733656.5A EP3645707A1 (fr) 2017-06-30 2018-07-02 Procédé de production de progéniteurs érythroïdes
PCT/EP2018/067833 WO2019002625A1 (fr) 2017-06-30 2018-07-02 Procédé de production de progéniteurs érythroïdes
AU2018293389A AU2018293389B2 (en) 2017-06-30 2018-07-02 Method for producing erythroid progenitor cells
JP2019572440A JP7162625B2 (ja) 2017-06-30 2018-07-02 赤血球系前駆細胞を作製する方法
CA3067551A CA3067551A1 (fr) 2017-06-30 2018-07-02 Procede de production de progeniteurs erythroides
KR1020207002966A KR102744512B1 (ko) 2017-06-30 2018-07-02 적혈구 전구체 세포의 생산 방법
CN201880044213.0A CN111373029B (zh) 2017-06-30 2018-07-02 产生红系祖细胞的方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1756222 2017-06-30
FR1756222A FR3068366B1 (fr) 2017-06-30 2017-06-30 Procede de production de progeniteurs erythroides

Publications (2)

Publication Number Publication Date
FR3068366A1 FR3068366A1 (fr) 2019-01-04
FR3068366B1 true FR3068366B1 (fr) 2023-11-24

Family

ID=60450747

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1756222A Active FR3068366B1 (fr) 2017-06-30 2017-06-30 Procede de production de progeniteurs erythroides

Country Status (9)

Country Link
US (1) US20200370015A1 (fr)
EP (1) EP3645707A1 (fr)
JP (1) JP7162625B2 (fr)
KR (1) KR102744512B1 (fr)
CN (1) CN111373029B (fr)
AU (1) AU2018293389B2 (fr)
CA (1) CA3067551A1 (fr)
FR (1) FR3068366B1 (fr)
WO (1) WO2019002625A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7194030B2 (ja) * 2019-01-30 2022-12-21 株式会社エビデント 赤血球モニタリング装置
WO2022089606A1 (fr) * 2020-10-30 2022-05-05 Westlake Therapeutics (Hangzhou) Co. Limited Procédés de préparation de globules rouges matures in vitro
JPWO2023277153A1 (fr) * 2021-06-30 2023-01-05
WO2024010317A1 (fr) * 2022-07-04 2024-01-11 주식회사 아트블러드 Établissement d'une lignée cellulaire progénitrice érythroïde immortalisée ayant une capacité supérieure de différenciation en globules rouges par l'utilisation d'une combinaison de surexpression génétique, son procédé de préparation et son utilisation
WO2024018018A1 (fr) * 2022-07-21 2024-01-25 Etablissement Francais Du Sang Utilisation d'un composé vitisine pour la production de cellules hématopoïétiques
WO2024237740A1 (fr) * 2023-05-18 2024-11-21 주식회사 레드진 Cellule transformée pour la production de globules rouges et son utilisation
CN116640728B (zh) * 2023-07-24 2023-10-20 呈诺再生医学科技(北京)有限公司 RO8191和AS2863619在诱导产生表达成人型β珠蛋白的脱核红细胞中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014DN06624A (fr) 2005-10-18 2015-07-10 Univ Colorado
EP1951881A4 (fr) 2005-11-07 2009-03-11 Gen Hospital Corp Procédés et compositions de modulation du vieillissement des cellules souches
CN101045914A (zh) 2006-03-29 2007-10-03 中国人民解放军军事医学科学院野战输血研究所 体外诱导造血干/祖细胞分化为成熟红细胞的方法与应用
US9169462B2 (en) 2008-07-21 2015-10-27 Taiga Biotechnologies, Inc. Methods for preparing mature erythrocytes from conditionally immortalized hematopoietic stem cells
US20120252697A1 (en) 2009-09-01 2012-10-04 Mcmaster University Transformed human pluripotent stem cells and associated methods
EP2500418B1 (fr) 2009-09-15 2018-01-17 The University of Tokyo Nouveau procédé de production de cellules différenciées
BR112012020958A2 (pt) * 2010-02-22 2015-09-15 Univ Paris Curie "meio de cultura para a criação e/ou diferenciação de células da linhagem hemapo
WO2013147082A1 (fr) * 2012-03-28 2013-10-03 株式会社クオリーメン Cellules souches immortalisées et composition médicinale et préparation médicinale comprenant un produit associé en tant que principe actif
JP2016135100A (ja) 2013-05-07 2016-07-28 学校法人金沢医科大学 赤芽球の脱核方法及び脱核赤血球の維持方法
WO2014186508A1 (fr) * 2013-05-15 2014-11-20 University Of Rechester Érythroblastes hautement auto-renouvelables (esre) humains
WO2016159376A1 (fr) 2015-04-03 2016-10-06 国立大学法人京都大学 Procédé de criblage pour identifier un agent thérapeutique contre le cancer
CA2997551A1 (fr) * 2015-09-04 2017-03-09 Memorial Sloan Kettering Cancer Center Compositions a base de cellules immunitaires et leurs procedes d'utilisation

Also Published As

Publication number Publication date
CN111373029B (zh) 2025-01-03
CN111373029A (zh) 2020-07-03
KR102744512B1 (ko) 2024-12-19
AU2018293389A1 (en) 2020-01-16
US20200370015A1 (en) 2020-11-26
CA3067551A1 (fr) 2019-01-03
JP7162625B2 (ja) 2022-10-28
EP3645707A1 (fr) 2020-05-06
FR3068366A1 (fr) 2019-01-04
KR20200060343A (ko) 2020-05-29
WO2019002625A1 (fr) 2019-01-03
JP2020525031A (ja) 2020-08-27
AU2018293389B2 (en) 2024-10-10

Similar Documents

Publication Publication Date Title
FR3068366B1 (fr) Procede de production de progeniteurs erythroides
EA201992795A1 (ru) Способ получения эукариотических клеток с отредактированной днк и набор, используемый в этом способе
AU2017254264A1 (en) Method for producing retinal tissue
PH12020500115A1 (en) cAMP RECEPTOR PROTEIN VARIANT AND METHOD OF PRODUCING L-AMINO ACID USING THE SAME
BR112015019997A2 (pt) Métodos de sacarificar e fermentar um material celulósico
AR069956A1 (es) Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas
MX2021004610A (es) Variante proteica receptora de ampc y procedimiento de produccion de l-aminoacido mediante el uso de la misma.
MX2020002851A (es) Biorreactor de perfusion y metodos de uso relacionados.
MX2021001528A (es) Metodo para la produccion de celulas positivas para cd3.
MX2021008920A (es) Un método de edición de genes.
BR112017020474A2 (pt) levedura modificada, meio de fermentação, método para produção de um bioproduto, ácido nucleico, vetor e método de fermentação para produzir etanol
BR112012029271A2 (pt) fungo isolado, método para produzir e kit para fabricar pelo menos um composto selecionado do grupo que consite de 1, 8-cineol, 1-metil-1,4-cicloexadieno, e (+) -a-metileno-a-fenchocanforona, molécula de ácido nucleico isolada de um fungo,e, método para gerar cepas mutantes de um fungo.
MX2022007696A (es) Celulas de levadura y metodos para la produccion de e8,e10-dodecadienil coenzima a, codlemona y derivados de las mismas.
FR3020379B1 (fr) Procede de production de methane par co-culture aerobie de microorganismes anaerobies
JOP20210271A1 (ar) نظم زراعة الخلية واستخداماتها
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
UA92157C2 (ru) Способ продуцирования гормона роста
AR113150A1 (es) Producción mejorada de etanol libre de glicerol
EP4389904A3 (fr) Micro-organismes pour la production de composés 4c-5c avec insaturation et procédés associés
MX2021002018A (es) Metodo para producir precursores neurales entericos.
WO2016149821A8 (fr) Procédés de fabrication d'alcaloïdes de type morphinane et enzymes associées
BR112016023823A2 (pt) método para produção de um produto de fermentação
PH12020550976A1 (en) Camp receptor protein variant and method of producing l-amino acid using the same
MX2022006994A (es) Metodos para generar celulas madre hematopoyeticas.
IN2015DN02381A (fr)

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20190104

PLFP Fee payment

Year of fee payment: 3

TQ Partial transmission of property

Owner name: ETABLISSEMENT FRANCAIS DU SANG, FR

Effective date: 20200313

Owner name: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA, FR

Effective date: 20200313

Owner name: SORBONNE UNIVERSITE, FR

Effective date: 20200313

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8